Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Burlington › NPI 1558392563
Hospital

Lahey Clinic Hospital, INC.

Lahey Clinic Hospital, INC. was paid $112.94M by Medicaid between Jan 2018 and Dec 2024, across 592 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 11% of everything it billed.

33Billing provider infoLAHEY CLINIC HOSPITAL, INC.
BURLINGTON, MA 01805
33aNPI1558392563assigned 07/06/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$112.94M
24GClaims3,168,326
24DCodes billed592
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Massachusetts

Rank by total paid#13 of 66
Median peer was paid$29.11M
This provider vs. median3.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018453,781$15.70M
2019497,579$16.73M
2020405,217$13.79M
2021506,349$18.32M
2022504,708$19.35M
2023454,281$17.47M
2024incomplete346,411$11.58M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 11% 90,799 77,670 $12.00M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6.2% 57,705 51,172 $7.01M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.6% 39,731 35,667 $6.32M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.7% 198,210 141,891 $5.34M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 4.1% 30,133 26,666 $4.66M
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 4.0% 35,731 32,801 $4.56M
96361 Intravenous infusion, hydration; each additional hour 3.9% 13,779 12,150 $4.35M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3.6% 33,620 29,375 $4.05M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.1% 23,955 22,081 $3.51M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.6% 21,446 19,802 $2.98M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.9% 36,286 13,876 $2.11M
J0585 Injection, onabotulinumtoxina, 1 unit 1.8% 5,137 3,211 $2.07M
580 more codes
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1.6% 2,306 $1.76M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.5% 3,086 $1.69M
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.4% 2,121 $1.61M
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1.4% 28,281 $1.59M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.2% 11,408 $1.32M
20610 1.1% 7,984 $1.26M
70450 Computed tomography, head or brain; without contrast material 1.0% 10,972 $1.14M
78815 Positron emission tomography (PET) for limited area imaging 1.0% 1,560 $1.13M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 5,235 $1.12M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 4,285 $1.10M
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 9,665 $1.07M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 6,463 $1.01M
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 10,766 $875K
62323 <1% 2,306 $852K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 22,278 $789K
77063 Screening digital breast tomosynthesis, bilateral <1% 12,279 $771K
74183 <1% 3,095 $723K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 5,699 $652K
67028 Intravitreal injection of a pharmacologic agent <1% 4,604 $643K
43235 <1% 971 $632K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 6,379 $629K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 4,587 $597K
11102 <1% 1,242 $568K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 17,500 $568K
64615 <1% 2,115 $554K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 4,323 $539K
80053 Comprehensive metabolic panel <1% 107,955 $471K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 3,627 $469K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 27,718 $467K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 4,861 $437K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 4,562 $434K
96415 <1% 2,022 $425K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 4,868 $425K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 109,505 $416K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 2,593 $411K
95806 <1% 502 $411K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,534 $404K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 12,942 $387K
93971 <1% 3,256 $378K
93975 <1% 4,193 $368K
97803 <1% 6,009 $368K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 21,576 $367K
76770 <1% 3,370 $367K
84443 Thyroid stimulating hormone (TSH) <1% 41,577 $367K
52000 <1% 518 $365K
77067 Screening mammography, bilateral, including computer-aided detection <1% 12,336 $341K
76830 Ultrasound, transvaginal <1% 4,001 $336K
97161 <1% 6,793 $322K
76642 <1% 3,270 $304K
G0378 Hospital observation service, per hour <1% 10,876 $302K
83036 Hemoglobin; glycosylated (A1C) <1% 57,088 $300K
31575 <1% 1,447 $292K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,204 $290K
95004 Percutaneous tests with allergenic extracts, immediate type reaction <1% 305 $290K
71250 <1% 5,618 $290K
J2357 Injection, omalizumab, 5 mg <1% 172 $279K
J3490 Unclassified drugs <1% 9,976 $268K
95886 <1% 1,546 $262K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 6,185 $255K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 9,358 $254K
71046 Radiologic examination, chest; 2 views <1% 22,093 $248K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,427 $248K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 9,289 $247K
76536 <1% 2,328 $244K
95811 <1% 363 $235K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 188 $235K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 3,629 $231K
31231 <1% 1,002 $219K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 846 $216K
S9485 Crisis intervention mental health services, per diem <1% 380 $214K
80048 Basic metabolic panel (calcium, ionized) <1% 62,449 $213K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 57,852 $210K
82607 <1% 24,883 $209K
80061 Lipid panel <1% 56,974 $203K
80050 General health panel <1% 10,084 $202K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 190 $197K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 16,060 $193K
85027 <1% 54,897 $190K
J0178 Injection, aflibercept, 1 mg <1% 438 $190K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 345 $189K
17110 <1% 1,073 $187K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 20,182 $181K
92340 Fitting of spectacles, except for aphakia; monofocal <1% 6,383 $179K
77080 <1% 3,291 $173K
94060 <1% 2,641 $166K
82728 <1% 21,716 $162K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 6,617 $157K
93321 <1% 947 $154K
92557 <1% 3,183 $145K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 12,384 $143K
84484 <1% 18,194 $143K
77065 Tomosynthesis, mammo <1% 1,961 $139K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 4,764 $136K
77066 Tomosynthesis, mammo <1% 1,633 $136K
84466 <1% 19,984 $136K
87631 <1% 2,119 $131K
G0105 Colorectal cancer screening; colonoscopy on individual at high risk <1% 106 $129K
73221 <1% 562 $129K
93351 <1% 1,082 $128K
86480 <1% 3,120 $124K
72141 <1% 690 $124K
84702 <1% 11,199 $122K
93017 <1% 1,701 $117K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,978 $115K
84153 <1% 8,806 $115K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 580 $115K
90686 <1% 5,738 $110K
83970 <1% 6,584 $108K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 15,649 $108K
86803 <1% 10,659 $108K
83735 <1% 36,447 $106K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 2,330 $105K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 5,653 $102K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 3,931 $101K
97802 <1% 1,402 $100K
92134 <1% 9,741 $96K
64493 <1% 120 $95K
83880 <1% 6,677 $92K
84403 <1% 5,783 $91K
93325 <1% 1,526 $91K
90750 <1% 1,001 $89K
85610 <1% 46,886 $89K
0011A <1% 3,168 $84K
95117 <1% 1,917 $82K
94010 <1% 2,316 $82K
86140 <1% 25,148 $80K
87086 Culture, bacterial; quantitative colony count, urine <1% 18,759 $75K
J1644 Injection, heparin sodium, per 1000 units <1% 6,472 $74K
ATP14 <1% 12,606 $74K
73562 <1% 7,118 $74K
73130 <1% 5,932 $73K
90715 <1% 3,106 $73K
J7030 Infusion, normal saline solution , 1000 cc <1% 23,345 $72K
83540 <1% 20,294 $71K
73630 <1% 7,667 $70K
Q3014 Telehealth originating site facility fee <1% 26,832 $70K
94729 <1% 3,239 $70K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 527 $69K
90792 Psychiatric diagnostic evaluation with medical services <1% 1,612 $69K
ATP08 <1% 12,889 $68K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 201 $68K
77336 <1% 1,127 $68K
99385 <1% 651 $68K
92083 <1% 3,038 $67K
0001A <1% 2,433 $67K
81003 <1% 54,999 $67K
73030 <1% 6,854 $64K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 2,144 $64K
99218 <1% 131 $63K
C9257 Injection, bevacizumab, 0.25 mg <1% 1,930 $63K
11100 <1% 290 $61K
87522 Neg quan hep c or qual rna <1% 1,906 $61K
84270 <1% 4,535 $61K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 17,146 $60K
72100 <1% 3,396 $60K
83690 <1% 13,957 $59K
11900 <1% 256 $58K
96375 Therapeutic injection; each additional sequential IV push <1% 14,223 $57K
17000 <1% 655 $56K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 94 $55K
92341 <1% 1,591 $55K
88342 <1% 3,292 $54K
73610 <1% 5,809 $54K
87088 <1% 11,916 $53K
49083 <1% 120 $53K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,569 $53K
62321 <1% 96 $52K
95018 <1% 432 $52K
0012A <1% 1,813 $52K
86780 <1% 4,478 $51K
92133 <1% 3,945 $50K
82746 <1% 6,150 $49K
82784 <1% 5,005 $48K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 2,270 $48K
82105 <1% 5,826 $48K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 728 $46K
87340 <1% 7,061 $46K
83516 <1% 3,744 $45K
84439 <1% 8,528 $43K
81025 <1% 7,990 $43K
86850 <1% 8,663 $42K
71271 <1% 982 $42K
86706 <1% 5,703 $41K
82043 <1% 17,461 $41K
90834 Psychotherapy session, about 45 minutes <1% 7,302 $40K
72125 Computed tomography, cervical spine; without contrast material <1% 3,916 $40K
86618 <1% 2,694 $39K
93970 <1% 332 $39K
93296 <1% 1,558 $39K
51798 <1% 5,645 $38K
98968 <1% 513 $38K
73110 <1% 4,351 $38K
86038 <1% 4,757 $38K
86704 <1% 4,782 $38K
73502 <1% 4,107 $37K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) <1% 2,885 $37K
87102 <1% 5,914 $36K
74178 <1% 193 $35K
82670 <1% 1,711 $35K
71045 Radiologic examination, chest; single view <1% 8,706 $35K
ATP15 <1% 6,071 $34K
99204 Doctor's office visit, new patient (more involved) <1% 343 $33K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,210 $33K
83001 <1% 2,372 $32K
86900 <1% 9,227 $32K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 5,128 $32K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 2,460 $32K
80076 <1% 9,927 $32K
94726 <1% 690 $31K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 233 $31K
0002A <1% 1,000 $31K
82248 <1% 24,957 $31K
87081 <1% 6,778 $31K
80197 <1% 8,279 $30K
70486 <1% 278 $28K
82274 <1% 1,755 $28K
82565 <1% 10,506 $28K
85379 <1% 4,505 $27K
77002 <1% 1,164 $27K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 776 $27K
87186 <1% 6,620 $27K
96367 <1% 181 $27K
83605 <1% 4,255 $27K
72197 <1% 100 $27K
82330 <1% 6,891 $27K
87205 <1% 9,113 $26K
97035 <1% 496 $26K
82570 <1% 11,800 $26K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 86 $25K
87634 <1% 550 $25K
86160 <1% 1,862 $25K
0064A <1% 983 $25K
70496 <1% 200 $24K
95885 <1% 146 $24K
86901 <1% 9,174 $24K
91322 <1% 349 $23K
84146 <1% 1,540 $23K
95024 <1% 135 $22K
72040 <1% 1,114 $22K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 17,904 $22K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 24 $22K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 16,196 $22K
84100 <1% 27,111 $22K
ATP17 <1% 7,997 $21K
99386 <1% 216 $21K
83002 <1% 1,449 $21K
90791 Psychiatric diagnostic evaluation <1% 1,774 $21K
95910 <1% 155 $20K
92567 <1% 3,395 $20K
95813 <1% 59 $20K
87077 <1% 4,875 $20K
88112 <1% 599 $20K
36415 Collection of venous blood by venipuncture <1% 99,039 $20K
86200 <1% 2,211 $20K
97165 <1% 250 $19K
A9585 Injection, gadobutrol, 0.1 ml <1% 11,287 $19K
J2704 Injection, propofol, 10 mg <1% 17,344 $19K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials <1% 369 $19K
84550 <1% 19,220 $18K
74018 <1% 1,549 $17K
87040 <1% 1,999 $17K
64635 <1% 54 $17K
73080 <1% 1,585 $17K
90662 <1% 2,728 $17K
84165 <1% 3,491 $17K
99203 Doctor's office visit, new patient (routine) <1% 205 $16K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 52 $15K
90677 <1% 649 $15K
83721 <1% 2,667 $15K
20553 <1% 88 $15K
99443 <1% 507 $15K
83921 <1% 1,225 $15K
ATP16 <1% 2,299 $15K
87070 <1% 3,286 $15K
20550 <1% 79 $15K
88307 <1% 306 $14K
77334 <1% 122 $14K
76882 <1% 126 $14K
76981 <1% 322 $14K
87147 <1% 1,681 $14K
85730 <1% 4,793 $14K
99442 <1% 814 $14K
G0444 Annual depression screening, 5 to 15 minutes <1% 6,784 $14K
84480 <1% 1,385 $13K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 13,831 $13K
64494 <1% 76 $13K
86334 <1% 1,193 $13K
J0690 Injection, cefazolin sodium, 500 mg <1% 6,628 $13K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 8,400 $12K
36591 <1% 3,466 $12K
86431 <1% 2,890 $11K
99441 <1% 189 $11K
77062 <1% 123 $11K
73564 <1% 1,645 $11K
0004A <1% 472 $11K
11721 <1% 765 $11K
83883 <1% 971 $11K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 112 $10K
84425 <1% 672 $10K
90732 <1% 544 $10K
82962 <1% 17,318 $10K
86235 <1% 101 $10K
94761 <1% 18,543 $10K
88304 <1% 1,286 $9K
95819 <1% 52 $9K
87497 <1% 1,205 $9K
J1650 Injection, enoxaparin sodium, 10 mg <1% 2,045 $9K
J1170 Injection, hydromorphone, up to 4 mg <1% 5,984 $9K
82550 <1% 4,773 $9K
86708 <1% 912 $9K
97162 <1% 158 $9K
93225 <1% 123 $9K
64405 <1% 29 $9K
85014 <1% 6,273 $9K
88341 <1% 386 $8K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 4,014 $8K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 45 $8K
G0008 Administration of influenza virus vaccine <1% 4,071 $8K
83718 <1% 1,335 $8K
83520 <1% 556 $8K
91301 <1% 2,540 $8K
11104 <1% 13 $8K
90670 <1% 276 $8K
90480 <1% 353 $8K
85018 <1% 3,271 $7K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,649 $7K
83521 <1% 912 $7K
82390 <1% 865 $7K
ATP03 <1% 9,275 $7K
58300 <1% 24 $7K
76870 <1% 41 $7K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) <1% 46 $7K
84460 <1% 5,610 $7K
0054A <1% 191 $7K
84450 <1% 4,853 $7K
82150 <1% 1,213 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 7,030 $6K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,180 $6K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 2,332 $6K
64636 <1% 107 $6K
0124A <1% 245 $6K
89051 <1% 1,830 $6K
57454 <1% 14 $6K
82040 <1% 4,082 $6K
99201 <1% 38 $6K
90472 Immunization administration, each additional vaccine (list separately) <1% 687 $5K
86769 <1% 210 $5K
97804 <1% 84 $5K
0134A <1% 230 $5K
87799 <1% 1,140 $5K
90832 Psychotherapy session, about 30 minutes <1% 1,840 $5K
84156 <1% 3,431 $5K
99205 Prolong outpt/office vis <1% 104 $5K
ATP11 <1% 2,062 $5K
86812 <1% 230 $5K
ATP07 <1% 1,248 $5K
84134 <1% 419 $5K
82172 <1% 325 $4K
81015 <1% 1,993 $4K
77061 <1% 51 $4K
74246 <1% 28 $4K
84630 <1% 458 $4K
83615 <1% 2,663 $4K
86364 <1% 685 $4K
86765 <1% 250 $4K
82985 <1% 570 $4K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 3,145 $4K
46600 <1% 69 $4K
90853 Group psychotherapy (other than of a multiple-family group) <1% 190 $4K
82610 <1% 604 $4K
82525 <1% 383 $4K
51702 <1% 1,065 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,367 $4K
96376 <1% 1,688 $4K
99406 <1% 312 $4K
80164 <1% 1,541 $3K
J1815 Injection, insulin, per 5 units <1% 1,139 $3K
96910 <1% 75 $3K
ATP18 <1% 1,610 $3K
93226 <1% 52 $3K
98967 <1% 56 $3K
86355 <1% 281 $3K
87427 <1% 144 $3K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 704 $3K
87517 <1% 122 $3K
82533 <1% 241 $3K
86255 <1% 339 $3K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 20,967 $3K
83090 <1% 208 $3K
84590 <1% 311 $3K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 26 $3K
J2060 Injection, lorazepam, 2 mg <1% 2,780 $3K
86225 <1% 356 $3K
84207 <1% 124 $3K
86695 <1% 117 $3K
86787 <1% 199 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,985 $3K
72202 <1% 82 $3K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,375 $3K
70498 <1% 113 $3K
81002 <1% 1,757 $2K
C1769 Guide wire <1% 1,500 $2K
86696 <1% 104 $2K
92285 <1% 438 $2K
84446 <1% 220 $2K
86381 <1% 129 $2K
87486 <1% 86 $2K
87581 <1% 86 $2K
83037 <1% 614 $2K
91300 <1% 1,758 $2K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 59 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 13 $2K
ATP09 <1% 493 $2K
0003A <1% 136 $2K
86735 <1% 70 $2K
86147 <1% 41 $2K
94760 <1% 12,421 $2K
0296T <1% 43 $2K
93880 <1% 53 $2K
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 4,249 $2K
90656 <1% 121 $2K
93299 <1% 25 $2K
86762 <1% 71 $2K
J1630 Injection, haloperidol, up to 5 mg <1% 1,376 $2K
76942 <1% 377 $2K
86376 <1% 94 $2K
73590 <1% 517 $2K
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination <1% 608 $1K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 4,129 $1K
87046 <1% 143 $1K
73140 <1% 219 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 20,513 $1K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 9,095 $1K
J7050 Infusion, normal saline solution, 250 cc <1% 404 $1K
82103 <1% 131 $1K
90746 <1% 25 $1K
92250 <1% 128 $1K
J1756 Injection, iron sucrose, 1 mg <1% 28 $1K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 540 $1K
87269 <1% 69 $1K
72131 <1% 38 $1K
87045 <1% 142 $1K
86146 <1% 25 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,706 $1K
80178 <1% 434 $1K
82378 <1% 183 $1K
82947 <1% 309 $1K
ATP04 <1% 455 $1K
86800 <1% 65 $1K
86356 <1% 49 $992.04
ATP10 <1% 401 $959.51
87272 <1% 69 $932.74
J3475 Injection, magnesium sulfate, per 500 mg <1% 377 $863.69
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 13 $818.60
G0009 Administration of pneumococcal vaccine <1% 790 $798.13
J0780 Injection, prochlorperazine, up to 10 mg <1% 500 $782.11
51705 <1% 60 $775.97
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 2,255 $734.38
J1071 Injection, testosterone cypionate, 1 mg <1% 501 $728.32
86015 <1% 100 $715.07
96417 <1% 64 $712.07
73522 <1% 13 $708.66
87075 <1% 161 $698.01
86003 <1% 12 $671.70
86617 <1% 13 $650.87
82785 <1% 52 $636.59
J1030 Injection, methylprednisolone acetate, 40 mg <1% 741 $634.48
99152 <1% 2,214 $615.30
88173 <1% 14 $612.83
86666 <1% 13 $586.05
82805 <1% 42 $555.84
88185 <1% 12 $544.76
72070 <1% 26 $542.64
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory <1% 274 $534.60
97116 <1% 74 $525.16
82977 <1% 168 $507.30
C9399 Unclassified drugs or biologicals <1% 103 $505.96
83021 <1% 32 $484.12
86036 <1% 43 $476.50
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 5,566 $466.42
99492 <1% 133 $463.21
86328 <1% 16 $461.62
86359 <1% 25 $458.41
86357 <1% 25 $458.41
99153 Mod sedat endo service >5yrs <1% 205 $457.97
ATP02 <1% 188 $418.26
82948 <1% 73 $417.24
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 1,204 $406.47
69209 <1% 13 $395.49
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 1,016 $381.92
82310 <1% 568 $367.85
0013A <1% 99 $366.96
85045 <1% 233 $351.51
85705 <1% 42 $345.58
83020 <1% 32 $345.02
85613 <1% 42 $343.62
84481 <1% 14 $339.14
ATP13 <1% 195 $326.70
J8540 Dexamethasone, oral, 0.25 mg <1% 791 $313.04
92136 <1% 120 $302.90
84520 <1% 819 $281.69
84132 <1% 390 $274.14
82627 <1% 13 $265.28
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 1,222 $257.17
86317 <1% 16 $237.96
93298 <1% 12 $237.05
86304 <1% 42 $235.95
87015 <1% 58 $225.07
ATP20 <1% 72 $223.82
73090 <1% 62 $218.26
86709 <1% 12 $205.77
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 12 $186.59
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 276 $186.30
85652 <1% 100 $160.45
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 2,437 $153.68
88312 <1% 14 $151.72
88313 <1% 54 $142.41
87338 <1% 14 $140.89
87207 <1% 13 $140.65
86308 <1% 25 $137.94
86711 <1% 32 $134.10
ATP19 <1% 77 $125.51
87324 <1% 12 $120.34
87449 <1% 12 $120.34
J3489 Injection, zoledronic acid, 1 mg <1% 13 $111.89
82077 <1% 59 $110.06
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 319 $100.80
91306 <1% 228 $95.52
88184 <1% 12 $92.82
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 3,655 $74.17
72170 <1% 74 $73.55
85004 <1% 165 $73.37
86360 <1% 13 $70.95
80069 <1% 91 $70.69
73552 <1% 96 $69.04
80175 <1% 30 $54.68
99493 <1% 271 $52.68
72156 <1% 13 $44.82
71101 <1% 13 $35.10
73060 <1% 50 $28.49
J1020 Injection, methylprednisolone acetate, 20 mg <1% 69 $15.25
80156 <1% 25 $15.03
80185 <1% 12 $13.67
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 758 $13.20
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 461 $11.81
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 403 $7.70
J1171 Injection, hydromorphone, 0.1 mg <1% 62 $5.04
J1010 Injection, methylprednisolone acetate, 1 mg <1% 256 $1.91
J7060 5% dextrose/water (500 ml = 1 unit) <1% 49 $1.31
J0670 Injection, mepivacaine hydrochloride, per 10 ml 0% 16 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 324 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 388 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 62 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 8,935 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 98 $0.00
91313 0% 67 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 144 $0.00
51741 0% 17 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 92 $0.00
76514 0% 12 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 0% 59 $0.00
92020 0% 16 $0.00
C1780 Lens, intraocular (new technology) 0% 110 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 28 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 22 $0.00
91312 0% 83 $0.00
90837 Psychotherapy session, about an hour 0% 19 $0.00
94664 0% 28 $0.00
99397 0% 12 $0.00
82523 0% 12 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 100 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 190 $0.00
V2632 Posterior chamber intraocular lens 0% 473 $0.00
G0442 Annual alcohol misuse screening, 5 to 15 minutes 0% 55 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 52 $0.00
91305 0% 55 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 14 $0.00
80177 0% 13 $0.00
C1773 Retrieval device, insertable (used to retrieve fractured medical devices) 0% 25 $0.00
C1726 Catheter, balloon dilatation, non-vascular 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLONGWORTH, DAVID (CEO)
Same official

Other billing entities under LONGWORTH, DAVID

Full network →
ProviderLocationPaid
Lahey Clinic Hospital INCPeabody, MA$42K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.